EDITORIAL CORRESPONDENCE / CONTACT
Send the Record, Not the Pitch
The desk welcomes precise corrections to citations, compound names, formulations, and study context.
What belongs in an editorial note
The most useful message identifies the page, the exact statement in question, and the source that supports a correction. Notes about mismatched aliases, duplicated publications, formulation confusion, population boundaries, inaccessible wording, or stale links are all within scope. A concise subject line such as “CJC-1295 identity correction” or “Tesamorelin citation note” helps route the review.
Correspondence may be addressed to editorial@unbrandedpeptides.com. This is an editorial mailbox, not a clinical service. Messages are evaluated against the cited record and the site’s core rule: the claim must remain attached to the correct molecule, form, study design, population, and endpoint. Submitting a suggestion does not guarantee publication, but specific, source-backed corrections receive priority.
What the desk cannot answer
The mailbox cannot provide medical advice, interpret symptoms, recommend a compound, propose a dose or schedule, assess personal risk, locate a seller, verify an outside product, or resolve an urgent health concern. Those requests require an appropriately licensed professional or, for emergencies, local emergency services. The site also does not accept sponsored placement, affiliate offers, product samples, or vendor listings.
For a literature question, include enough bibliographic detail to distinguish a primary study from a review or duplicate publication, but do not send private health information. For a name-mapping question, include the code, nonproprietary name, salt or formulation, and the source in which it appears. That information lets the desk review the identity record without expanding into personal guidance.